BNTX - BioNTech SE - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BNTX is currently covered by 19 analysts with an average price target of $129.43. This is a potential upside of $38.14 (41.78%) from yesterday's end of day stock price of $91.29.

BioNTech SE's activity chart (see below) currently has 366 price targets and 293 ratings on display. The stock rating distribution of BNTX is 26.32% HOLD and 73.68% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.15% with an average time for these price targets to be met of 44.16 days.

Highest price target for BNTX is $171, Lowest price target is $94, average price target is $129.43.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 14-Oct-2026. First documented stock forecast 04-Nov-2019.

Best performing analysts who are covering BNTX - BioNTech SE:

Shanshan Xu Etzer Darout Chris Shibutani Yifeng Liu Arlinda Lee Akash Tewari

Currently out of the existing stock ratings of BNTX, 10 are a HOLD (26.32%), 28 are a BUY (73.68%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Nov-2024

$132

$44.29 (50.50%)

$136

8 days ago
(14-Oct-2026)

0/7 (0%)

$43.34 (48.88%)

Buy Since 11-Mar-2025

$114

$26.29 (29.97%)

$119

15 days ago
(07-Oct-2026)

3/13 (23.08%)

$18.75 (19.69%)

46

Buy Since 05-Sep-2025

$105

$17.29 (19.71%)

$128

1 months 14 days ago
(08-Sep-2026)

0/3 (0%)

$6.34 (6.43%)

Buy Since 08-Aug-2022

$125

$37.29 (42.52%)

$130

2 months 17 days ago
(05-Aug-2026)

0/6 (0%)

$32.82 (35.60%)

Buy Since 04-Aug-2025

$130

$42.29 (48.22%)

$130

2 months 17 days ago
(05-Aug-2026)

4/7 (57.14%)

$37.82 (41.03%)

23

Show more analysts

Please expand the browser size to see the chart

What is BNTX (BioNTech SE) average time for price targets to be met?

On average it took 44 days for the stock forecasts to be reached, with an average price target met ratio of 40.15%.

Which analyst most recently updated their price target on BNTX (BioNTech SE)?

John Newman

Which analyst has the most public recommendations on BNTX (BioNTech SE)?

John Newman works at CANACCORD and has 53 price targets and 42 ratings on BNTX

Which analyst is the currently most bullish on BNTX (BioNTech SE)?

Olga Smolentseva with the highest potential upside of $363.29

Which analyst is the currently most reserved on BNTX (BioNTech SE)?

Emmanuel Papadakis with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?